![conference banner](/images/conference-banner.jpeg)
Abstract
The first review regarding the potential of aurones as promising drug candidates was reported in 2003. Since, considerable efforts have been made to explore the pharmacological and therapeutical activities of aurones. In this regard, many biological areas were concerned, including major pathological, such as cancer and neurodegenerative disorders. The aim of the present report is to highlight the progress made during the last ten years on the medicinal chemistry of aurones. A special focus will be made on the structure-activity relationship aspects among aurones and especially in case where aurones were found highly active than the corresponding flavones and chalcones.
Keywords: Alzheimer’s disease, antioxidants, aureusidin, antiviral, aurones, cancer, cytotoxicity, flavonoids, hepatitis C, kinases, sulfuretin, tyrosinase
Current Medicinal Chemistry
Title:Recent Advances in the Medicinal Chemistry of Aurones
Volume: 19 Issue: 18
Author(s): R. Haudecoeur and A. Boumendjel
Affiliation:
Keywords: Alzheimer’s disease, antioxidants, aureusidin, antiviral, aurones, cancer, cytotoxicity, flavonoids, hepatitis C, kinases, sulfuretin, tyrosinase
Abstract: The first review regarding the potential of aurones as promising drug candidates was reported in 2003. Since, considerable efforts have been made to explore the pharmacological and therapeutical activities of aurones. In this regard, many biological areas were concerned, including major pathological, such as cancer and neurodegenerative disorders. The aim of the present report is to highlight the progress made during the last ten years on the medicinal chemistry of aurones. A special focus will be made on the structure-activity relationship aspects among aurones and especially in case where aurones were found highly active than the corresponding flavones and chalcones.
Export Options
About this article
Cite this article as:
Haudecoeur R. and Boumendjel A., Recent Advances in the Medicinal Chemistry of Aurones, Current Medicinal Chemistry 2012; 19 (18) . https://dx.doi.org/10.2174/092986712800672085
DOI https://dx.doi.org/10.2174/092986712800672085 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cocos nucifera Linn. (Palmae) Husk Fiber Ethanolic Extract: Antioxidant Capacity and Electrochemical Investigation
Combinatorial Chemistry & High Throughput Screening Amyotrophic Lateral Sclerosis: A Genetic Point of View
Current Molecular Medicine Neurodegeneration in Niemann-Pick Type C Disease and Huntingtons Disease: Impact of Defects in Membrane Trafficking
Current Drug Targets MG17, A Novel Triazole Derivative Abrogated Neuroinflammation and Related Neurodegenerative Symptoms in Rodents
Current Molecular Pharmacology Curcumin and Curcumin Derivatives for Therapeutic Applications: <i>In vitro</i> and <i>In vivo</i> Studies
Current Nutrition & Food Science Melittin: A Natural Peptide with Expanded Therapeutic Applications
The Natural Products Journal Editorial (Thematic Issue: Endocrine Disorders and Cognitive Function in the Elderly)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Combining Antimicrobial Peptides with Nanotechnology: An Emerging Field in Theranostics
Current Protein & Peptide Science Role of Prolyl Isomerase Pin1 in Pathogenesis of Diseases and Remedy for the Diseases from Natural Products
Current Drug Targets Protein Nano-Fibrilar Structure and Associated Diseases
Current Proteomics Synaptic Elimination in Neurological Disorders
Current Neuropharmacology Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimers Disease
Mini-Reviews in Medicinal Chemistry Pharmacophore Based 3D-QSAR Modeling and Molecular Docking of Leucettines as Potent Dyrk1A Inhibitors
Letters in Drug Design & Discovery A Key Role for Connexin Hemichannels in Spreading Ischemic Brain Injury
Current Drug Targets Editorial [Hot Topic: Emerging Roles of the Unfolded Protein Response Signaling in Physiology and Disease (Executive Editor: Claudio A. Hetz and Claudio Soto )]
Current Molecular Medicine Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders
Current Neuropharmacology Modeling Neuronal Diseases in Zebrafish in the Era of CRISPR
Current Neuropharmacology Aluminum Excytotoxicity and NeuroAutotoImmunity: The Role of the Brain Expression of CD32+ (FcγRIIa), ICAM-1+ and CD3ع in Aging
Current Aging Science A Systematic Review on Traumatic Brain Injury Pathophysiology and Role of Herbal Medicines in its Management
Current Neuropharmacology Application of Carbon Nanotubes In Drug Delivery of Non-cancerous Diseases: A Review
Current Pharmaceutical Design